| Identification | Back Directory | [Name]
1-(2,3,5-Tribenzoyl--D-ribofuranosyl)-5-nitropyridine-2(1H)-one | [CAS]
59892-37-4 | [Synonyms]
1-(2,3,5-Tribenzoyl--D-ribofuranosyl)-5-nitropyridine-2(1H)-one
1-(2,3,5-Tribenzoyl-O-D-ribofuranosyl)-5-nitropyridine-2(1H)-one
1-(2,3,5-Tri-O-benzoyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one
2(1H)-Pyridinone, 5-nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-
5-Nitro-1-(2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)-2(1H)-pyridinone | [Molecular Formula]
C31H24N2O10 | [MDL Number]
MFCD25542532 | [MOL File]
59892-37-4.mol | [Molecular Weight]
584.53 |
| Hazard Information | Back Directory | [Uses]
5-Nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2(1H)-pyridinone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|